{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:16:12Z","timestamp":1772165772691,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 macular neovascularization (MNV) is supposed to be a rare condition in age-related macular degeneration (AMD). The main purpose of this study was to assess accompanying factors of type 2 MNV in AMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective data analysis of eyes previously diagnosed with neovascular AMD in a tertiary eye care center (Medical Retina Unit, Rudolf Foundation Hospital, Vienna, Austria) between June 2008 and December 2017. Drusen subtypes, fibrosis, atrophy and subfoveal choroidal thickness (SFCT) of both eyes in patients with type 2 MNV lesions were categorized based on multimodal imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Type 2 MNV was diagnosed in 27 (3.2%) of 835 eyes (749 patients). Drusen characteristics in type 2 MNV were observed as followed: drusen &lt;\u200963\u2009\u03bcm in 2 eyes (7.4%), drusen \u226563\u2009\u03bcm in 10 eyes (37%), subretinal drusenoid deposits (SDD) in 8 eyes (29.6%), cuticular drusen in 2 eye (7.4%) and no drusen were evident in 10 eyes (37%). Drusen distribution in 23 fellow eyes was detected as followed: drusen &lt;\u200963\u2009\u03bcm in 2 eyes (8.7%), drusen \u226563\u2009\u03bcm in 9 eyes (39.1%), SDD in 5 eyes (21.7%), cuticular drusen in 1 eye (4.3%) and no drusen were evident in 9 eyes (39.1%). Mean SFCT was 140\u2009\u00b1\u200949\u2009\u03bcm in affected eyes and 152\u2009\u00b1\u200941\u2009\u03bcm in the fellow eyes. Patients with drusen or SDD were significantly younger (mean 70.88\u2009\u00b1\u20096.85,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) than patients without deposits (mean 77.40\u2009\u00b1\u20095.74).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Type 2 MNV remains a rare entity in AMD. It was frequently seen in the absence of drusen, a hallmark of AMD. These findings contribute to the heterogeneity of phenotypes related to pure type 2 lesions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-020-01651-2","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T08:03:03Z","timestamp":1601020983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration"],"prefix":"10.1186","volume":"20","author":[{"given":"Daniel","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Krepler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8032-4686","authenticated-orcid":false,"given":"Siamak","family":"Ansari-Shahrezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119:1417\u201336.","journal-title":"Arch Ophthalmol"},{"key":"1651_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","volume":"120","author":"FL Ferris","year":"2013","unstructured":"Ferris FL, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, et al. Clinical classification of age-related macular degeneration. Ophthalmology. 2013;120:844\u201351.","journal-title":"Ophthalmology."},{"key":"1651_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ophtha.2015.10.029","volume":"123","author":"RP Finger","year":"2016","unstructured":"Finger RP, Chong E, McGuinness MB, Robman LD, Aung KZ, Giles G, et al. Reticular Pseudodrusen and their association with age-related macular degeneration: the Melbourne collaborative cohort study. Ophthalmology. 2016;123:599\u2013608.","journal-title":"Ophthalmology."},{"key":"1651_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ophtha.2009.07.014","volume":"117","author":"SA Zweifel","year":"2010","unstructured":"Zweifel SA, Spaide RF, Curcio CA, Malek G, Imamura Y. Reticular pseudodrusen are subretinal drusenoid deposits. Ophthalmology. 2010;117:303\u2013312.e1.","journal-title":"Ophthalmology"},{"key":"1651_CR5","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.ophtha.2010.01.027","volume":"117","author":"SA Zweifel","year":"2010","unstructured":"Zweifel SA, Imamura Y, Spaide TC, Fujiwara T, Spaide RF. Prevalence and significance of subretinal drusenoid deposits (reticular pseudodrusen) in age-related macular degeneration. Ophthalmology. 2010;117:1775\u201381.","journal-title":"Ophthalmology."},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/IAE.0b013e3181ee5ce8","volume":"30","author":"RF Spaide","year":"2010","unstructured":"Spaide RF, Curcio CA. Drusen characterization with multimodal imaging. Retina (Philadelphia, Pa). 2010;30:1441\u201354.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"1651_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.preteyeres.2016.04.008","volume":"53","author":"KN Khan","year":"2016","unstructured":"Khan KN, Mahroo OA, Khan RS, Mohamed MD, McKibbin M, Bird A, et al. Differentiating drusen: Drusen and drusen-like appearances associated with ageing, age-related macular degeneration, inherited eye disease and other pathological processes. Prog Retin Eye Res. 2016;53:70\u2013106.","journal-title":"Prog Retin Eye Res"},{"key":"1651_CR8","unstructured":"Spaide RF, IMPROVING THE, AGE-RELATED MACULARDEGENERATIONCONSTRUCT. A new classification system. Retina (Philadelphia, Pa). 2017."},{"key":"1651_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting Neovascular age-related macular degeneration data: consensus on Neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020;127:616\u201336.","journal-title":"Ophthalmology."},{"key":"1651_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/ceo.13114","volume":"46","author":"KK Dansingani","year":"2018","unstructured":"Dansingani KK, Gal-Or O, Sadda SR, Yannuzzi LA, Freund KB. Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of \u201cexpanded spectra\u201d - a review. Clin Exp Ophthalmol. 2018;46:189\u2013200.","journal-title":"Clin Exp Ophthalmol"},{"key":"1651_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/IAE.0b013e3181e7976b","volume":"30","author":"KB Freund","year":"2010","unstructured":"Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration? Retina (Philadelphia, Pa). 2010;30:1333\u201349.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"1651_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ajo.2014.07.006","volume":"158","author":"JJ Jung","year":"2014","unstructured":"Jung JJ, Chen CY, Mrejen S, Gallego-Pinazo R, Xu L, Marsiglia M, et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. Am J Ophthalmol. 2014;158:769\u2013779.e2.","journal-title":"Am J Ophthalmol"},{"key":"1651_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/IAE.0000000000000758","volume":"36","author":"J Naysan","year":"2016","unstructured":"Naysan J, Jung JJ, Dansingani KK, Balaratnasingam C, Freund KB. Type 2 (subretinal) neovascularization in age-related macular degeneration associated with pure reticular pseudodrusen phenotype. Retina (Philadelphia, Pa). 2016;36:449\u201357.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"1651_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ophtha.2006.10.040","volume":"114","author":"R Klein","year":"2007","unstructured":"Klein R, Klein BEK, Knudtson MD, Meuer SM, Swift M, Gangnon RE. Fifteen-year cumulative incidence of age-related macular degeneration: the beaver dam eye study. Ophthalmology. 2007;114:253\u201362.","journal-title":"Ophthalmology."},{"key":"1651_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000329473","volume":"226","author":"R Silva","year":"2011","unstructured":"Silva R, Cachulo ML, Fonseca P, Bernardes R, Nunes S, Vilhena N, et al. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Ophthalmologica. 2011;226:110\u20138.","journal-title":"Ophthalmologica."},{"key":"1651_CR16","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1167\/iovs.15-18572","volume":"57","author":"NS Abdelfattah","year":"2016","unstructured":"Abdelfattah NS, Zhang H, Boyer DS, Rosenfeld PJ, Feuer WJ, Gregori G, et al. Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye. Invest Ophthalmol Vis Sci. 2016;57:1839\u201346.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1651_CR17","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/eye.2009.301","volume":"24","author":"S George","year":"2010","unstructured":"George S, Cooke C, Chakravarthy U. Exudative AMD subtypes and eligibility for treatment with ranibizumab. Eye (Lond). 2010;24:1247\u201351.","journal-title":"Eye (Lond)"},{"key":"1651_CR18","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1136\/bjo.2007.115501","volume":"91","author":"SY Cohen","year":"2007","unstructured":"Cohen SY, Creuzot-Garcher C, Darmon J, Desmettre T, Korobelnik JF, Levrat F, et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol. 2007;91:1173\u20136.","journal-title":"Br J Ophthalmol"},{"key":"1651_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.ophtha.2003.05.030","volume":"111","author":"TW Olsen","year":"2004","unstructured":"Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration. Ophthalmology. 2004;111:250\u20135.","journal-title":"Ophthalmology."},{"key":"1651_CR20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0002-9394(14)73649-9","volume":"115","author":"KB Freund","year":"1993","unstructured":"Freund KB, Yannuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol. 1993;115:786\u201391.","journal-title":"Am J Ophthalmol"},{"key":"1651_CR21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.ajo.2014.01.025","volume":"157","author":"M Suzuki","year":"2014","unstructured":"Suzuki M, Sato T, Spaide RF. Pseudodrusen subtypes as delineated by multimodal imaging of the fundus. Am J Ophthalmol. 2014;157:1005\u201312.","journal-title":"Am J Ophthalmol"},{"key":"1651_CR22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2017.08.033","volume":"125","author":"C Balaratnasingam","year":"2018","unstructured":"Balaratnasingam C, Cherepanoff S, Dolz-Marco R, Killingsworth M, Chen FK, Mendis R, et al. Cuticular Drusen: clinical phenotypes and natural history defined using multimodal imaging. Ophthalmology. 2018;125:100\u201318.","journal-title":"Ophthalmology."},{"key":"1651_CR23","first-page":"496","volume":"41","author":"FC Delori","year":"2000","unstructured":"Delori FC, Fleckner MR, Goger DG, Weiter JJ, Dorey CK. Autofluorescence distribution associated with drusen in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:496\u2013504.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1651_CR24","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1167\/iovs.05-1318","volume":"47","author":"RT Smith","year":"2006","unstructured":"Smith RT, Chan JK, Busuoic M, Sivagnanavel V, Bird AC, Chong NV. Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:5495\u2013504.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1651_CR25","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/S0161-6420(92)31768-3","volume":"99","author":"D Pauleikhoff","year":"1992","unstructured":"Pauleikhoff D, Zuels S, Sheraidah GS, Marshall J, Wessing A, Bird AC. Correlation between biochemical composition and fluorescein binding of deposits in Bruch\u2019s membrane. Ophthalmology. 1992;99:1548\u201353.","journal-title":"Ophthalmology."},{"key":"1651_CR26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0002-9394(14)70826-8","volume":"124","author":"JJ Arnold","year":"1997","unstructured":"Arnold JJ, Quaranta M, Soubrane G, Sarks SH, Coscas G. Indocyanine green angiography of drusen. Am J Ophthalmol. 1997;124:344\u201356.","journal-title":"Am J Ophthalmol"},{"key":"1651_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00006982-200306000-00004","volume":"23","author":"JL Prenner","year":"2003","unstructured":"Prenner JL, Rosenblatt BJ, Tolentino MJ, Ying G-S, Javornik NB, Maguire MG, et al. Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT. Retina (Philadelphia, Pa). 2003;23:307\u201314.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"1651_CR28","first-page":"511","volume":"13","author":"G Mimoun","year":"1990","unstructured":"Mimoun G, Soubrane G, Coscas G. Macular drusen. J Fr Ophtalmol. 1990;13:511\u201330.","journal-title":"J Fr Ophtalmol"},{"key":"1651_CR29","volume-title":"Stereoscopic atlas of macular diseases: diagnosis and treatment","author":"JDM Gass","year":"1977","unstructured":"Gass JDM. Stereoscopic atlas of macular diseases: diagnosis and treatment. 2d ed. St. Louis: C. V. Mosby; 1977.","edition":"2d ed."},{"key":"1651_CR30","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0161-6420(95)30968-2","volume":"102","author":"AC Ho","year":"1995","unstructured":"Ho AC, Yannuzzi LA, Pisicano K, DeRosa J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology. 1995;102:782\u20139.","journal-title":"Ophthalmology."},{"key":"1651_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ophtha.2009.12.002","volume":"117","author":"C Cukras","year":"2010","unstructured":"Cukras C, Agr\u00f3n E, Klein ML, Ferris FL, Chew EY, Gensler G, et al. Natural history of Drusenoid pigment epithelial detachment in age-related macular degeneration: AREDS report number 28. Ophthalmology. 2010;117:489\u201399.","journal-title":"Ophthalmology."},{"key":"1651_CR32","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1016\/j.ophtha.2011.05.008","volume":"118","author":"Z Yehoshua","year":"2011","unstructured":"Yehoshua Z, Wang F, Rosenfeld PJ, Penha FM, Feuer WJ, Gregori G. Natural history of drusen morphology in age-related macular degeneration using spectral domain optical coherence tomography. Ophthalmology. 2011;118:2434\u201341.","journal-title":"Ophthalmology."},{"key":"1651_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.survophthal.2018.05.005","volume":"63","author":"RF Spaide","year":"2018","unstructured":"Spaide RF, Ooto S, Curcio CA. Subretinal drusenoid deposits AKA pseudodrusen. Surv Ophthalmol. 2018;63:782\u2013815.","journal-title":"Surv Ophthalmol"},{"key":"1651_CR34","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5301\/ejo.5000661","volume":"26","author":"C Wilde","year":"2016","unstructured":"Wilde C, Patel M, Lakshmanan A, Morales MA, Dhar-Munshi S, Amoaku WMK. Prevalence of reticular pseudodrusen in eyes with newly presenting neovascular age-related macular degeneration. Eur J Ophthalmol. 2016;26:128\u201334.","journal-title":"Eur J Ophthalmol"},{"key":"1651_CR35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1097\/IAE.0000000000000460","volume":"35","author":"M Marsiglia","year":"2015","unstructured":"Marsiglia M, Boddu S, Chen CY, Jung JJ, Mrejen S, Gallego-Pinazo R, et al. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration. Retina (Philadelphia, Pa). 2015;35:966\u201374.","journal-title":"Retina (Philadelphia, Pa)"},{"key":"1651_CR36","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/bjo.87.3.307","volume":"87","author":"S Abugreen","year":"2003","unstructured":"Abugreen S, Muldrew KA, Stevenson MR, VanLeeuwen R, DeJong PTVM, Chakravarthy U. CNV subtype in first eyes predicts severity of ARM in fellow eyes. Br J Ophthalmol. 2003;87:307\u201311.","journal-title":"Br J Ophthalmol"}],"updated-by":[{"DOI":"10.1186\/s12886-020-01699-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000}}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-020-01651-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-020-01651-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T19:25:27Z","timestamp":1632511527000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-020-01651-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1186\/s12886-020-01651-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.14559\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14559\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14559\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14559\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14559\/v1","asserted-by":"object"}]},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,25]]},"assertion":[{"value":"6 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Federal Hospitals Act \u00a715a Abs. 3a states that a vote from the Viennese ethics committee is not obligatory for this study design. In the medical retina unit of the Rudolf Foundation Hospital, patients sign a waiver as part of their informed consent form for treatment or diagnostics indicating that anonymized clinical data may be used for scientific research unless patients specifically opted not to do so.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"381"}}